Elliptic Laboratories (Norway) Executives

ELABS Stock  NOK 2.92  -0.07  -2.34%   
Elliptic Laboratories employs about 69 people. The company is managed by 8 executives with a total tenure of roughly 161 years, averaging almost 20.0 years of service per executive, having 8.63 employees per reported executive. For Elliptic Laboratories AS, management analysis can help investors test whether leadership decisions are reinforcing the broader investment thesis or creating new operating risk. Used properly, management analysis helps separate durable execution from results that may only reflect a supportive market cycle.
Tobias Dahl  Insider
Founder
Lars Holmoy  Insider
CFO Relations
  
Elliptic Laboratories has a market cap of 2.04 B, operating margin of -24.28%, ROE of -2.89%. See Investing Opportunities for portfolio-level analysis. This suggests a position in Elliptic Laboratories AS inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Elliptic Laboratories Management Team Effectiveness

The company has return on total asset (ROA) of -3.28 % indicating that it generated a loss of $3.28 on every 100 dollars of assets. This is considerably below sector benchmarks. Similarly, it shows a return on equity (ROE) of -2.89 %, suggesting that it is not yet earning a positive return on equity.

Stock Ownership Analysis

About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.17. Elliptic Laboratories had not issued any dividends in recent years. The company completed a 10:1 stock split on 30th of September 2021.

Outstanding Bonds

Reviewing Elliptic Laboratories AS bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.
Elliptic Laboratories holds a significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Of Elliptic Laboratories' outstanding shares, about 26% are institutional, 31% insider-held, and 42% in the public float.

Elliptic Stock Holders Distribution

Institutional ownership analysis for Elliptic Laboratories AS matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.

Elliptic Laboratories Workforce Comparison

Elliptic Laboratories AS takes the leading position in number of employees compared to key competitors. The total workforce of Software—Application industry is currently estimated at about 2,537. Elliptic Laboratories holds roughly 69.0 in number of employees claiming about 2.72% of equities listed under Software—Application industry.
The company has Profit Margin (PM) of -12.0 %, which suggests it has not yet achieved a profitable pricing equilibrium. This is considerably below sector benchmarks. Similarly, it shows Operating Margin (OM) of -24.0 %, which indicates that it loses $24.0 on every $100 of revenue generated.

Elliptic Laboratories Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Elliptic Laboratories Price Series Multiplication is a cross multiplication of Elliptic Laboratories price series and its benchmark/peer.

Elliptic Laboratories Notable Stakeholders

Stakeholders matter for Elliptic Laboratories because not every influential participant is a shareholder acting with the same objective or time horizon. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.

Management Information & Data Sources

Elliptic Laboratories is a large-cap company. Executive review focuses on insiders, senior management, and employee signals. Employee and executive trends can help explain changes in cost structure, growth capacity, or strategic execution. CEO is Laila Danielsen with 69 employees and 8 reported executives.

This section for Elliptic Laboratories AS is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor

Workforce Efficiency and Productivity

Investors reviewing Elliptic Laboratories AS can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.

Elliptic Laboratories Manpower Efficiency

Return on Elliptic Laboratories Manpower

Revenue Per Employee791.3K
Revenue Per Executive6.8M
Net Loss Per Employee189.7K
Net Loss Per Executive1.6M

More Resources for Elliptic Stock Analysis

Other Information on Investing in Elliptic Stock

Financial ratios for Elliptic Laboratories provide valuation context across profits, cash flow, and enterprise value. They help compare Elliptic across valuation measures in a consistent way.